GH56 Capsules

· Suzhou Genhouse Bio Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GH56 Capsules, covering 2025-03-28 to 2025-03-28. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ia/Ib Clinical Study of GH56 Capsules in Subjects With MTAP-Deleted Advanced Solid Tumors [Phase 1]